Physician profile
David J Laub
NPI 1982652780
$11,867.33
in general payments reported to CMS, 2019-2025
50 companies · $2,411 in 2025
The $2,411 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $1,461 · 2021: $1,520 · 2022: $1,823 · 2023: $2,321 · 2024: $1,391 · 2025: $2,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,105 · Debt Forgiveness: $873 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,104.95 |
| Debt Forgiveness | $872.95 |
| Education | $144.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,299.62 | 2019-2025 | |
| Olympus America INC. | $1,053.50 | 2022-2025 | Itind System |
| Coloplast Corp | $919.24 | 2019-2025 | Titan |
| Edap Technomed INC | $742.00 | 2021-2023 | |
| Histosonics, INC. | $600.73 | 2024-2025 | |
| Astellas Pharma US INC | $548.16 | 2019-2025 | Myrbetriq, Xtandi |
| Biotissue Holdings INC. | $513.67 | 2023 | |
| Allergan, INC. | $439.94 | 2019-2022 | |
| Neotract INC. | $414.45 | 2020 | |
| Progenics Pharmaceuticals, INC. | $382.37 | 2022-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $380.17 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $358.40 | 2019-2025 | |
| Janssen Biotech, INC. | $343.53 | 2019-2025 | Erleada, Akeega, Balversa |
| Boston Scientific Corporation | $342.74 | 2019-2020 | |
| Procept Biorobotics Corporation | $306.24 | 2019-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $265.96 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $225.78 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $219.17 | 2023-2025 | Orgovyx, Gemtesa |
| Alnylam Pharmaceuticals INC. | $207.63 | 2022-2025 | Oxlumo |
| Palette Life Sciences, INC. | $174.69 | 2022 | |
| Photocure INC | $173.72 | 2020-2024 | Cysview |
| Abc Home Medical Supply, INC. | $165.39 | 2022-2024 | |
| Blue Earth Diagnostics | $150.08 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $143.47 | 2019-2025 | Adstiladrin |
| 180 Medical, INC. | $132.33 | 2023-2025 | |
| Endo USA, INC. | $131.50 | 2024-2025 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $127.41 | 2020-2022 | |
| Antares Pharma, INC. | $118.80 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Isoray, INC | $91.69 | 2022 | |
| Myriad Genetic Laboratories, INC. | $85.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $85.68 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $76.92 | 2022-2024 | Lynparza |
| Urogen Pharma, INC. | $71.28 | 2021-2023 | Jelmyto |
| Smith+Nephew, INC. | $70.63 | 2022-2024 | Stravix |
| Accord Healthcare, INC. | $57.64 | 2024-2025 | |
| Teleflex LLC | $55.45 | 2022-2025 | Urolift |
| Sagent Pharmaceuticals | $45.45 | 2019-2025 | Glydo |
| Axonics, INC. | $39.96 | 2022 | |
| Halozyme INC | $35.09 | 2023 | |
| Hollister Incorporated | $34.90 | 2024 | Vapro |
| Medtronic, INC. | $34.22 | 2024 | Ligasure |
| Dendreon Pharmaceuticals LLC | $30.69 | 2023 | Provenge |
| Becton, Dickinson and Company | $26.09 | 2024 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $24.70 | 2022 | |
| Immunitybio, INC. | $24.14 | 2024 | |
| Innovation Technologies INC | $22.66 | 2021 | |
| Merck Sharp & Dohme LLC | $21.51 | 2021 | |
| Verity Pharmaceuticals INC. | $18.02 | 2025 | Tlando |
| Conmed Corporation | $17.18 | 2024 | Conmed Specimen Retrieval |
| Intuitive Surgical, INC. | $16.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Laub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.